Literature DB >> 7873838

Acrodermatitis chronica atrophicans involving the face. Evidence for Borrelia burgdorferi infection confirmed by DNA amplification.

D E Müller1, P H Itin, S A Büchner, T Rufli.   

Abstract

In a female patient with increasing redness of the hands and face, proteins of Borrelia burgdorferi were detected in a biopsy of the ear by DNA amplification. Although acrodermatitis chronica atrophicans has been documented to be caused by B. burgdorferi, this is the first case with proven spirochetal presence in the skin of the head. After 2 weeks of intravenous therapy with ceftriaxone marked improvement of discoloration of the skin was noted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873838     DOI: 10.1159/000246901

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  4 in total

1.  [Diagnosis and treatment of Lyme arthritis. Recommendations of the Pharmacotherapy Commission of the Deutsche Gesellschaft für Rheumatologie (German Society for Rheumatology)].

Authors:  M Gaubitz; F Dressler; H I Huppertz; A Krause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

Review 2.  PCR in laboratory diagnosis of human Borrelia burgdorferi infections.

Authors:  B L Schmidt
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

3.  Acrodermatitis chronica atrophicans: various faces of the late form of Lyme borreliosis.

Authors:  Anna Moniuszko-Malinowska; Piotr Czupryna; Justyna Dunaj; Sławomir Pancewicz; Adam Garkowski; Maciej Kondrusik; Sambor Grygorczuk; Joanna Zajkowska
Journal:  Postepy Dermatol Alergol       Date:  2018-07-19       Impact factor: 1.837

4.  Chronic Lyme Disease: An Evidence-Based Definition by the ILADS Working Group.

Authors:  Samuel Shor; Christine Green; Beatrice Szantyr; Steven Phillips; Kenneth Liegner; Joseph Jr Burrascano; Robert Bransfield; Elizabeth L Maloney
Journal:  Antibiotics (Basel)       Date:  2019-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.